Clinical Trial Update: Sculptra Aesthetic Post-Approval Study [Phase 4]

View source ↗

Summary

Phase 4 post-approval study for Sculptra Aesthetic evaluating nasolabial fold contour deficiencies and wrinkles has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasolabial Fold Contour Deficiencies
• Wrinkles

Drugs mentioned

• Sculptra Aesthetic (poly-L-lactic acid)

Snippet

Sponsor: Galderma R&D | Conditions: Nasolabial Fold Contour Deficiencies, Wrinkles | Phase 4 | Status: COMPLETED | Results posted: 2023-07-27